The disruption of TGFβ/Smad-dependent signaling during the progression of esophageal adenocarcinoma was confirmed by a report that showed Smad4 mRNA expression was progressively reduced in the metaplasia-dysplasia-adenocarcinoma sequence by promoter methylation [4]. The gene discussed is TGFB1; the disease is dysplasia.